Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 20 versus OSMITROL 10 IN WATER IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 20 versus OSMITROL 10 IN WATER IN PLASTIC CONTAINER.
MANNITOL 20% vs OSMITROL 10% IN WATER IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Increases plasma osmolality, drawing water from intracellular and interstitial spaces into the extracellular fluid, thereby reducing intracranial pressure and promoting diuresis.
Increases plasma osmolality, drawing water from tissues into the bloodstream, thereby reducing intracranial pressure and cerebral edema.
Adult: 50-100 g intravenously as a 20% solution over 30-60 minutes. For cerebral edema: 0.25-1 g/kg IV over 30-60 minutes. For oliguric acute kidney injury: test dose 0.2 g/kg IV over 3-5 minutes.
Initial: 0.25–1 g/kg (25–100 mL of 10% solution) IV over 30–60 minutes. May repeat every 6–12 hours if needed. Typical adult dose: 50–100 g IV. Maximum: 2 g/kg per dose.
None Documented
None Documented
Terminal elimination half-life 1.1–1.6 hours in normal renal function; prolonged to 18–36 hours in anuria/end-stage renal disease.
Terminal half-life approximately 1.5 hours in normal renal function; prolonged in renal impairment (up to 36 hours in anuria).
Renal, >90% unchanged by glomerular filtration; negligible biliary (<2%) or fecal elimination.
Primarily renal; >90% excreted unchanged in urine via glomerular filtration; <5% biliary/fecal.
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic